<DOC>
	<DOCNO>NCT01632761</DOCNO>
	<brief_summary>The VITamin D OmegaA-3 TriaL ( VITAL ; NCT01169259 ) randomize clinical trial 20,000 U.S. men woman study whether take daily dietary supplement vitamin D3 ( 2000 IU ) omega-3 fatty acid ( OmacorÂ® fish oil , 1 gram ) reduce risk develop cancer , heart disease , stroke people prior history illness . This ancillary study conduct among VITAL participant study whether vitamin D fish oil : ( A ) overall VITAL cohort , reduce number person diagnose anemia ( B ) subcohort 900 participant see Boston , effect long-term change protein blood anemic non-anemic individual provide blood sample start study 2 year later .</brief_summary>
	<brief_title>Effects Vitamin D Marine Omega-3 Fatty Acids Anemia</brief_title>
	<detailed_description>The VITamin D OmegA-3 Trial ( VITAL ; NCT01169259 ) randomize clinical trial vitamin D ( form D3 [ cholecalciferol ] ) marine omega-3 fatty acid ( eicosapentaenoic acid [ EPA ] + docosahexaenoic acid [ DHA ] ) supplement primary prevention cancer cardiovascular disease . Eligible participant assign chance ( like coin toss ) one four group : ( 1 ) daily vitamin D3 omega-3 ; ( 2 ) daily vitamin D3 omega-3 placebo ; ( 3 ) daily vitamin D omega-3 ; ( 4 ) daily vitamin D placebo omega-3 placebo . Participants equal chance assign four group 3 4 chance get least one active agent . Participants group take two pill day -- one softgel contain either vitamin D3 vitamin D placebo one capsule contain either omega-3 omega-3 placebo . Participants receive study pill convenient calendar package via U.S. mail . Participants also fill short ( 15-20 minute ) questionnaire year . The questionnaire ask health ; lifestyle habit physical exercise , diet , smoking ; use medication dietary supplement ; family history illness , new medical diagnosis . Occasionally participant may receive phone call study staff collect information clarify responses question . If participant report new medical diagnosis anemia short questionnaire , invited participate sub-study . If participant consent , medical record review confirm diagnosis anemia . We expect roughly 1,100 individual develop anemia study . Of expect 20,000 participant VITAL trial , approximately 1,000 participant see Boston give opportunity participate optional research blood draw . This sub-study expect receive approximately 10mL sample collect 900 participant . This portion blood use evaluate amount different protein anemic non-anemic individual . Blood sample collect baseline two year later .</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Participants VITAL ( NCT 01169259 ) anemia baseline report diagnosis anemia VITAL followup questionnaire eligible participate ancillary study .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>anemia</keyword>
	<keyword>vitamin D3</keyword>
	<keyword>omega-3 fatty acid</keyword>
	<keyword>fish oil</keyword>
	<keyword>primary prevention</keyword>
</DOC>